newsfilter
← Latest News
GlobeNewswire·

Applied Therapeutics Reports First Quarter 2025 Financial Results

- Company to present full 12-month clinical data and new topline 18-month and 24-month data from INSPIRE registrational Phase 3 trial of govorestat in CMT-SORD Deficiency at the Peripheral Nerve Society 2025 Annual